Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

被引：36

作者：

Jones, Eric D. ^{[1
]}

Vandegraaff, Nick ^{[1
]}

Le, Giang ^{[1
]}

Choi, Neil ^{[1
]}

Issa, William ^{[1
]}

Macfarlane, Katherine ^{[1
]}

Thienthong, Neeranat ^{[1
]}

Winfield, Lisa J. ^{[1
]}

Coates, Jonathan A. V. ^{[1
]}

Lu, Long ^{[2
]}

Li, Xinming ^{[2
]}

Feng, Xiao ^{[2
]}

Yu, Changjiang ^{[2
]}

Rhodes, David I. ^{[1
]}

Deadman, John J. ^{[1
]}

机构：

[1] Avexa Ltd, Richmond, Vic 3121, Australia

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期

关键词：

Integrase; Inhibitor; Synthesis; 3-Hydroxy-pyrido[12-a]pyrimidin-4-one;

D O I：

10.1016/j.bmcl.2010.07.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented. Nine variations of the core scaffold are evaluated leading to optimization of the 6:6 core giving compound 48 with an EC50 of 3 nM against wild type HIV infected T-cells. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5913 / 5917

页数：5

共 50 条

[11] Solid-phase synthesis of potential HIV-1 integrase inhibitors.
Lin, ZW
Neamati, N
Pommier, Y
Burke, TR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1207 - U1207
[12] Design of second generation HIV-1 integrase inhibitors
Deng, Jinxia
Dayam, Raveendra
Al-Mawsawi, Laith Q.
Neamati, Nouri
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (02) : 129 - 141
[13] An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors
Wilson, Tyler A.
Koneru, Pratibha C.
Rebensburg, Stephanie V.
Lindenberger, Jared J.
Kobe, Matthew J.
Cockroft, Nicholas T.
Adu-Arnpratwum, Daniel
Larue, Ross C.
Kvaratskhelia, Mamuka
Fuchs, James R.
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (02): : 215 - 220
[14] A QSAR Study on Some Series of HIV-1 Integrase Inhibitors
Kaushik, Shikha
Gupta, Satya P.
Sharma, P. K.
Anwar, Zaihra
MEDICINAL CHEMISTRY, 2011, 7 (06) : 553 - 560
[15] Studies of nonnueleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides
Masuda, N
Yamamoto, O
Fujii, M
Ohgami, T
Fujiyasua, J
Kontani, T
Moritomo, A
Orita, M
Kurihara, H
Koga, H
Nakahara, H
Kageyama, S
Ohta, M
Inoue, H
Hatta, T
Suzuki, H
Sudo, K
Shimizu, Y
Kodama, E
Matsuoka, M
Fujiwara, M
Yokota, T
Shigeta, S
Baba, M
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (23) : 6171 - 6182
[16] Structure activity relationship of disulfone-containing HIV-1 integrase inhibitors.
Meadows, DC
Gervay-Hague, J
Matthews, TB
North, TW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U169 - U169
[17] Bicyclic Hydroxy-1H-pyrrolopyridine-trione Containing HIV-1 Integrase Inhibitors
Zhao, Xue Zhi
Maddali, Kasthuraiah
Metifiot, Mathieu
Smith, Steven J.
Vu, B. Christie
Marchand, Christophe
Hughes, Stephen H.
Pommier, Yves
Burke, Terrence R., Jr.
CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (02) : 157 - 165
[18] The future of integrase inhibitors of HIV-1
Malet, Isabelle
Calvez, Vincent
Marcelin, Anne-Genevieve
CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 580 - 587
[19] The hunt for HIV-1 integrase inhibitors
Lataillade, Max
Kozal, Michael J.
AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 489 - 501
[20] Arylamide inhibitors of HIV-1 integrase
Zhao, H
Neamati, N
Mazumder, A
Sunder, S
Pommier, Y
Burke, TR
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194

← 1 2 3 4 5 →